Atea Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $70k | 13k | 5.38 |
| 2025-03-31 | $90k | 30k | 2.99 |
| 2024-12-31 | $256k | 76k | 3.35 |
| 2024-09-30 | $148k | 44k | 3.35 |
| 2024-03-31 | $271k | 67k | 4.04 |
| 2023-12-31 | $159k | 52k | 3.05 |
| 2023-09-30 | $273k | 91k | 3.00 |
| 2023-06-30 | $330k | 88k | 3.74 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management